These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 2820669
1. Prognosis of patients after retroperitoneal lymphadenectomy for clinical stage I nonseminomatous germ cell tumour of the testis. Hornák M, Zvara V, Ondrus D, Bárdos A. Czech Med; 1987; 10(2):109-16. PubMed ID: 2820669 [Abstract] [Full Text] [Related]
2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L, German Testicular Cancer Study Group. J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815 [Abstract] [Full Text] [Related]
4. [Urologic treatment of testicular germ cell cancer]. Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ. Arch Esp Urol; 2002 Oct 20; 55(8):927-36. PubMed ID: 12455283 [Abstract] [Full Text] [Related]
5. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J. J Urol; 2007 Mar 20; 177(3):937-42; discussion 942-3. PubMed ID: 17296380 [Abstract] [Full Text] [Related]
6. Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer. Pizzocaro G. Eur J Surg Oncol; 1986 Mar 20; 12(1):25-8. PubMed ID: 3007218 [Abstract] [Full Text] [Related]
7. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE. J Urol; 2008 Jan 20; 179(1):163-6. PubMed ID: 18001800 [Abstract] [Full Text] [Related]
8. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle. Yoon GH, Stein JP, Skinner DG. Expert Rev Anticancer Ther; 2005 Feb 20; 5(1):75-85. PubMed ID: 15757440 [Abstract] [Full Text] [Related]
9. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified? Divrik RT, Akdoğan B, Ozen H, Zorlu F. J Urol; 2006 Oct 20; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649 [Abstract] [Full Text] [Related]
10. [Primary laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ-cell testis tumor]. Castillo OA, Sánchez-Salas R, Secin FP, Campero JM, Foneron A, Vidal-Mora I. Actas Urol Esp; 2011 Jan 20; 35(1):22-8. PubMed ID: 21256391 [Abstract] [Full Text] [Related]
11. Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis. Sogani PC. Urol Clin North Am; 1991 Aug 20; 18(3):561-73. PubMed ID: 1652171 [Abstract] [Full Text] [Related]
12. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer. Williams SB, Steele GS, Richie JP. J Urol; 2009 Dec 20; 182(6):2716-20. PubMed ID: 19836777 [Abstract] [Full Text] [Related]
13. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE. J Urol; 1999 Apr 20; 161(4):1148-52. PubMed ID: 10081858 [Abstract] [Full Text] [Related]
14. [Nerve sparing retroperitoneal lymphadenectomy with intraoperative electrostimulation in patients with nonseminomatous testicular tumors]. Huland H, Dieckmann KP, Sauerwein D. Urologe A; 1992 Jan 20; 31(1):1-7. PubMed ID: 1313195 [Abstract] [Full Text] [Related]
15. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers? Powles T. Hematol Oncol Clin North Am; 2011 Jun 20; 25(3):517-27,viii. PubMed ID: 21570606 [Abstract] [Full Text] [Related]
16. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors. Lowe BA. Urol Clin North Am; 1993 Feb 20; 20(1):75-83. PubMed ID: 8381999 [Abstract] [Full Text] [Related]
17. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? Beck SD, Cheng L, Bihrle R, Donohue JP, Foster RS. J Urol; 2007 Mar 20; 177(3):944-6. PubMed ID: 17296383 [Abstract] [Full Text] [Related]
18. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors. Sternberg CN. Urol Clin North Am; 1993 Feb 20; 20(1):93-109. PubMed ID: 8382000 [Abstract] [Full Text] [Related]
19. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R. J Urol; 2004 Jan 20; 171(1):172-6. PubMed ID: 14665870 [Abstract] [Full Text] [Related]
20. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J. J Urol; 2005 Aug 20; 174(2):557-60; discussion 560. PubMed ID: 16006891 [Abstract] [Full Text] [Related] Page: [Next] [New Search]